West Pharmaceutical
205 hedge funds and large institutions have $2.57B invested in West Pharmaceutical in 2013 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 75 increasing their positions, 83 reducing their positions, and 13 closing their positions.
77% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 13
4% more funds holding
Funds holding: 197 → 205 (+8)
3% more capital inflows, than outflows
Capital inflows: $254M | Capital outflows: $246M
0.73% less ownership
Funds ownership: 90.22% → 89.49% (-0.73%)
10% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 83
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
+$32.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.7M |
| 3 |
OppenheimerFunds
New York
|
+$29.1M |
| 4 |
RS Investment Management
San Francisco,
California
|
+$23.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hermes Investment Management
London Uk,
United Kingdom
|
-$28.5M |
| 2 |
Champlain Investment Partners
Burlington,
Vermont
|
-$27.8M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$17.5M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$16.9M |
| 5 |
Denver Investment Advisors
Denver,
Colorado
|
-$15.2M |
WST Hedge Fund Activity: Q3 2013 in Review
205 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2013, worth a combined $2.57B — up 17% from $2.19B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new WST positions and 13 closed out — a net gain of 10 holders — while 75 added to existing stakes and 83 trimmed.
The largest buyer was BAMCO Inc, adding an estimated $32.7M. The largest seller was Hermes Investment Management, cutting an estimated $28.5M.
- 205 institutional investors held West Pharmaceutical (WST) as of Q3 2013, up from 197 in Q2 2013.
- Funds reported $2.57B of West Pharmaceutical stock for Q3 2013, up 17% quarter-over-quarter.
- 23 funds opened new West Pharmaceutical positions in Q3 2013 and 13 closed out, a net change of +10 holders.
- The largest West Pharmaceutical buyer in Q3 2013 was BAMCO Inc, an estimated $32.7M added.
- The largest West Pharmaceutical seller in Q3 2013 was Hermes Investment Management, an estimated $28.5M sold.
Based on aggregated 13F filings for Q3 2013.